nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP2C9—brain cancer	0.634	1	CbGaD
Alosetron—CYP1A2—Carmustine—brain cancer	0.0818	0.297	CbGbCtD
Alosetron—CYP3A4—Temozolomide—brain cancer	0.0618	0.225	CbGbCtD
Alosetron—CYP3A4—Lomustine—brain cancer	0.0526	0.191	CbGbCtD
Alosetron—CYP2E1—Etoposide—brain cancer	0.0419	0.152	CbGbCtD
Alosetron—CYP1A2—Etoposide—brain cancer	0.0242	0.0881	CbGbCtD
Alosetron—HTR3A—fourth ventricle—brain cancer	0.0162	0.489	CbGeAlD
Alosetron—CYP3A4—Etoposide—brain cancer	0.0127	0.0462	CbGbCtD
Alosetron—HTR3A—cranial nerve—brain cancer	0.00578	0.174	CbGeAlD
Alosetron—Ondansetron—CYP2C9—brain cancer	0.00424	1	CrCbGaD
Alosetron—HTR3A—ganglion—brain cancer	0.00292	0.0881	CbGeAlD
Alosetron—Balance disorder—Procarbazine—brain cancer	0.00195	0.0361	CcSEcCtD
Alosetron—Contusion—Lomustine—brain cancer	0.00193	0.0356	CcSEcCtD
Alosetron—HTR3A—brainstem—brain cancer	0.00127	0.0383	CbGeAlD
Alosetron—HTR3A—telencephalon—brain cancer	0.00113	0.034	CbGeAlD
Alosetron—Haemorrhoids—Temozolomide—brain cancer	0.0011	0.0203	CcSEcCtD
Alosetron—Photophobia—Procarbazine—brain cancer	0.001	0.0185	CcSEcCtD
Alosetron—Burning sensation—Carmustine—brain cancer	0.00096	0.0178	CcSEcCtD
Alosetron—Tenderness—Hydroxyurea—brain cancer	0.000946	0.0175	CcSEcCtD
Alosetron—Ulcer—Hydroxyurea—brain cancer	0.000873	0.0161	CcSEcCtD
Alosetron—Haemoglobin—Lomustine—brain cancer	0.000848	0.0157	CcSEcCtD
Alosetron—Haemorrhage—Lomustine—brain cancer	0.000844	0.0156	CcSEcCtD
Alosetron—Nail disorder—Etoposide—brain cancer	0.000795	0.0147	CcSEcCtD
Alosetron—Alopecia—Lomustine—brain cancer	0.000745	0.0138	CcSEcCtD
Alosetron—Drug interaction—Carmustine—brain cancer	0.000719	0.0133	CcSEcCtD
Alosetron—HTR3A—head—brain cancer	0.000702	0.0212	CbGeAlD
Alosetron—Infection—Carboplatin—brain cancer	0.000681	0.0126	CcSEcCtD
Alosetron—HTR3A—central nervous system—brain cancer	0.000641	0.0193	CbGeAlD
Alosetron—Pollakiuria—Procarbazine—brain cancer	0.000618	0.0114	CcSEcCtD
Alosetron—Infection—Lomustine—brain cancer	0.000595	0.011	CcSEcCtD
Alosetron—Pain—Carboplatin—brain cancer	0.000586	0.0108	CcSEcCtD
Alosetron—Jaundice—Procarbazine—brain cancer	0.000581	0.0108	CcSEcCtD
Alosetron—Sweating—Procarbazine—brain cancer	0.000572	0.0106	CcSEcCtD
Alosetron—Ulcer—Etoposide—brain cancer	0.000545	0.0101	CcSEcCtD
Alosetron—Haemoglobin—Procarbazine—brain cancer	0.000538	0.00996	CcSEcCtD
Alosetron—Haemorrhage—Procarbazine—brain cancer	0.000536	0.00991	CcSEcCtD
Alosetron—Gastroenteritis—Temozolomide—brain cancer	0.000528	0.00977	CcSEcCtD
Alosetron—Injury—Carmustine—brain cancer	0.000527	0.00975	CcSEcCtD
Alosetron—CYP2E1—telencephalon—brain cancer	0.000524	0.0158	CbGeAlD
Alosetron—HTR3A—brain—brain cancer	0.000509	0.0153	CbGeAlD
Alosetron—Arrhythmia—Procarbazine—brain cancer	0.000478	0.00885	CcSEcCtD
Alosetron—Alopecia—Procarbazine—brain cancer	0.000473	0.00876	CcSEcCtD
Alosetron—Tremor—Procarbazine—brain cancer	0.000437	0.00808	CcSEcCtD
Alosetron—Haemoglobin—Hydroxyurea—brain cancer	0.000417	0.00771	CcSEcCtD
Alosetron—Haemorrhage—Hydroxyurea—brain cancer	0.000414	0.00767	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000413	0.00764	CcSEcCtD
Alosetron—CYP2E1—medulla oblongata—brain cancer	0.000411	0.0124	CbGeAlD
Alosetron—Abdominal distension—Temozolomide—brain cancer	0.000407	0.00754	CcSEcCtD
Alosetron—Cough—Procarbazine—brain cancer	0.000407	0.00753	CcSEcCtD
Alosetron—Hypertension—Procarbazine—brain cancer	0.000402	0.00745	CcSEcCtD
Alosetron—Myalgia—Procarbazine—brain cancer	0.000397	0.00734	CcSEcCtD
Alosetron—Anxiety—Procarbazine—brain cancer	0.000396	0.00732	CcSEcCtD
Alosetron—Dry mouth—Procarbazine—brain cancer	0.000388	0.00718	CcSEcCtD
Alosetron—Confusional state—Procarbazine—brain cancer	0.000384	0.0071	CcSEcCtD
Alosetron—Vomiting—Lomustine—brain cancer	0.000381	0.00705	CcSEcCtD
Alosetron—Infection—Procarbazine—brain cancer	0.000378	0.00699	CcSEcCtD
Alosetron—Hyperglycaemia—Carmustine—brain cancer	0.000378	0.00699	CcSEcCtD
Alosetron—Upper respiratory tract infection—Temozolomide—brain cancer	0.000376	0.00696	CcSEcCtD
Alosetron—Pollakiuria—Temozolomide—brain cancer	0.000374	0.00691	CcSEcCtD
Alosetron—Depression—Carmustine—brain cancer	0.000372	0.00689	CcSEcCtD
Alosetron—Hyperhidrosis—Procarbazine—brain cancer	0.000368	0.00681	CcSEcCtD
Alosetron—CYP1A2—endocrine gland—brain cancer	0.000367	0.0111	CbGeAlD
Alosetron—CYP2E1—spinal cord—brain cancer	0.000367	0.0111	CbGeAlD
Alosetron—Alopecia—Hydroxyurea—brain cancer	0.000366	0.00678	CcSEcCtD
Alosetron—Hyperglycaemia—Temozolomide—brain cancer	0.000365	0.00675	CcSEcCtD
Alosetron—Urinary tract infection—Carmustine—brain cancer	0.000363	0.00671	CcSEcCtD
Alosetron—Depression—Temozolomide—brain cancer	0.00036	0.00665	CcSEcCtD
Alosetron—Nausea—Lomustine—brain cancer	0.000356	0.00659	CcSEcCtD
Alosetron—Urinary tract infection—Temozolomide—brain cancer	0.000351	0.00649	CcSEcCtD
Alosetron—CYP2C9—endocrine gland—brain cancer	0.000349	0.0105	CbGeAlD
Alosetron—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000347	0.00641	CcSEcCtD
Alosetron—Sinusitis—Temozolomide—brain cancer	0.000338	0.00626	CcSEcCtD
Alosetron—Cramp muscle—Etoposide—brain cancer	0.000337	0.00624	CcSEcCtD
Alosetron—Haemoglobin—Carmustine—brain cancer	0.000337	0.00623	CcSEcCtD
Alosetron—Haemorrhage—Carmustine—brain cancer	0.000335	0.0062	CcSEcCtD
Alosetron—Ill-defined disorder—Hydroxyurea—brain cancer	0.000335	0.00619	CcSEcCtD
Alosetron—Hypoaesthesia—Carmustine—brain cancer	0.000333	0.00617	CcSEcCtD
Alosetron—CYP2E1—endocrine gland—brain cancer	0.00033	0.00995	CbGeAlD
Alosetron—Alanine aminotransferase increased—Etoposide—brain cancer	0.00033	0.00611	CcSEcCtD
Alosetron—Fatigue—Procarbazine—brain cancer	0.000328	0.00607	CcSEcCtD
Alosetron—CYP2E1—head—brain cancer	0.000326	0.00983	CbGeAlD
Alosetron—Haemoglobin—Temozolomide—brain cancer	0.000325	0.00602	CcSEcCtD
Alosetron—Malaise—Hydroxyurea—brain cancer	0.000325	0.00602	CcSEcCtD
Alosetron—Pain—Procarbazine—brain cancer	0.000325	0.00602	CcSEcCtD
Alosetron—Constipation—Procarbazine—brain cancer	0.000325	0.00602	CcSEcCtD
Alosetron—Haemorrhage—Temozolomide—brain cancer	0.000324	0.00599	CcSEcCtD
Alosetron—Hepatitis—Temozolomide—brain cancer	0.000324	0.00599	CcSEcCtD
Alosetron—Hypoaesthesia—Temozolomide—brain cancer	0.000322	0.00596	CcSEcCtD
Alosetron—Feeling abnormal—Procarbazine—brain cancer	0.000314	0.0058	CcSEcCtD
Alosetron—Discomfort—Hydroxyurea—brain cancer	0.000303	0.00562	CcSEcCtD
Alosetron—Urticaria—Procarbazine—brain cancer	0.000302	0.00559	CcSEcCtD
Alosetron—Arrhythmia—Carmustine—brain cancer	0.000299	0.00554	CcSEcCtD
Alosetron—CYP2E1—central nervous system—brain cancer	0.000298	0.00897	CbGeAlD
Alosetron—Alopecia—Carmustine—brain cancer	0.000296	0.00548	CcSEcCtD
Alosetron—Infection—Hydroxyurea—brain cancer	0.000293	0.00541	CcSEcCtD
Alosetron—CYP2E1—cerebellum—brain cancer	0.000291	0.00877	CbGeAlD
Alosetron—Alopecia—Temozolomide—brain cancer	0.000286	0.00529	CcSEcCtD
Alosetron—Skin disorder—Hydroxyurea—brain cancer	0.000286	0.00529	CcSEcCtD
Alosetron—Jaundice—Etoposide—brain cancer	0.000281	0.00521	CcSEcCtD
Alosetron—Hypersensitivity—Procarbazine—brain cancer	0.00028	0.00519	CcSEcCtD
Alosetron—Tremor—Carmustine—brain cancer	0.000273	0.00506	CcSEcCtD
Alosetron—Asthenia—Procarbazine—brain cancer	0.000273	0.00505	CcSEcCtD
Alosetron—CYP3A4—endocrine gland—brain cancer	0.000266	0.00801	CbGeAlD
Alosetron—Tremor—Temozolomide—brain cancer	0.000264	0.00489	CcSEcCtD
Alosetron—Ill-defined disorder—Temozolomide—brain cancer	0.000262	0.00484	CcSEcCtD
Alosetron—Hypoaesthesia—Etoposide—brain cancer	0.000258	0.00477	CcSEcCtD
Alosetron—Malaise—Temozolomide—brain cancer	0.000254	0.0047	CcSEcCtD
Alosetron—Fatigue—Hydroxyurea—brain cancer	0.000254	0.0047	CcSEcCtD
Alosetron—Hypertension—Carmustine—brain cancer	0.000252	0.00466	CcSEcCtD
Alosetron—Pain—Hydroxyurea—brain cancer	0.000252	0.00466	CcSEcCtD
Alosetron—Constipation—Hydroxyurea—brain cancer	0.000252	0.00466	CcSEcCtD
Alosetron—Myalgia—Carmustine—brain cancer	0.000248	0.00459	CcSEcCtD
Alosetron—Anxiety—Carmustine—brain cancer	0.000247	0.00458	CcSEcCtD
Alosetron—Cough—Temozolomide—brain cancer	0.000246	0.00455	CcSEcCtD
Alosetron—Hypertension—Temozolomide—brain cancer	0.000243	0.0045	CcSEcCtD
Alosetron—Feeling abnormal—Hydroxyurea—brain cancer	0.000243	0.00449	CcSEcCtD
Alosetron—Vomiting—Procarbazine—brain cancer	0.000242	0.00448	CcSEcCtD
Alosetron—Confusional state—Carmustine—brain cancer	0.00024	0.00444	CcSEcCtD
Alosetron—Myalgia—Temozolomide—brain cancer	0.00024	0.00444	CcSEcCtD
Alosetron—Rash—Procarbazine—brain cancer	0.00024	0.00444	CcSEcCtD
Alosetron—Dermatitis—Procarbazine—brain cancer	0.00024	0.00443	CcSEcCtD
Alosetron—CYP3A4—central nervous system—brain cancer	0.00024	0.00722	CbGeAlD
Alosetron—Anxiety—Temozolomide—brain cancer	0.000239	0.00442	CcSEcCtD
Alosetron—Headache—Procarbazine—brain cancer	0.000238	0.00441	CcSEcCtD
Alosetron—Discomfort—Temozolomide—brain cancer	0.000237	0.00439	CcSEcCtD
Alosetron—Infection—Carmustine—brain cancer	0.000236	0.00438	CcSEcCtD
Alosetron—CYP2E1—brain—brain cancer	0.000236	0.00712	CbGeAlD
Alosetron—Dry mouth—Temozolomide—brain cancer	0.000235	0.00434	CcSEcCtD
Alosetron—Confusional state—Temozolomide—brain cancer	0.000232	0.00429	CcSEcCtD
Alosetron—Alopecia—Etoposide—brain cancer	0.000229	0.00424	CcSEcCtD
Alosetron—Infection—Temozolomide—brain cancer	0.000229	0.00423	CcSEcCtD
Alosetron—Nausea—Procarbazine—brain cancer	0.000226	0.00418	CcSEcCtD
Alosetron—Skin disorder—Temozolomide—brain cancer	0.000223	0.00413	CcSEcCtD
Alosetron—Hyperhidrosis—Temozolomide—brain cancer	0.000222	0.00411	CcSEcCtD
Alosetron—Hypersensitivity—Hydroxyurea—brain cancer	0.000217	0.00401	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Carmustine—brain cancer	0.000217	0.00401	CcSEcCtD
Alosetron—Muscle spasms—Etoposide—brain cancer	0.000217	0.00401	CcSEcCtD
Alosetron—Asthenia—Hydroxyurea—brain cancer	0.000211	0.00391	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00021	0.00388	CcSEcCtD
Alosetron—Ill-defined disorder—Etoposide—brain cancer	0.000209	0.00387	CcSEcCtD
Alosetron—Pain—Carmustine—brain cancer	0.000204	0.00377	CcSEcCtD
Alosetron—Constipation—Carmustine—brain cancer	0.000204	0.00377	CcSEcCtD
Alosetron—Malaise—Etoposide—brain cancer	0.000203	0.00376	CcSEcCtD
Alosetron—Fatigue—Temozolomide—brain cancer	0.000198	0.00367	CcSEcCtD
Alosetron—Cough—Etoposide—brain cancer	0.000197	0.00364	CcSEcCtD
Alosetron—Pain—Temozolomide—brain cancer	0.000197	0.00364	CcSEcCtD
Alosetron—Constipation—Temozolomide—brain cancer	0.000197	0.00364	CcSEcCtD
Alosetron—Feeling abnormal—Carmustine—brain cancer	0.000196	0.00363	CcSEcCtD
Alosetron—Hypertension—Etoposide—brain cancer	0.000195	0.0036	CcSEcCtD
Alosetron—Discomfort—Etoposide—brain cancer	0.00019	0.00351	CcSEcCtD
Alosetron—Feeling abnormal—Temozolomide—brain cancer	0.00019	0.00351	CcSEcCtD
Alosetron—Vomiting—Hydroxyurea—brain cancer	0.000187	0.00346	CcSEcCtD
Alosetron—Rash—Hydroxyurea—brain cancer	0.000186	0.00344	CcSEcCtD
Alosetron—Confusional state—Etoposide—brain cancer	0.000186	0.00343	CcSEcCtD
Alosetron—Dermatitis—Hydroxyurea—brain cancer	0.000185	0.00343	CcSEcCtD
Alosetron—Headache—Hydroxyurea—brain cancer	0.000184	0.00341	CcSEcCtD
Alosetron—Infection—Etoposide—brain cancer	0.000183	0.00338	CcSEcCtD
Alosetron—Urticaria—Temozolomide—brain cancer	0.000183	0.00338	CcSEcCtD
Alosetron—Skin disorder—Etoposide—brain cancer	0.000179	0.00331	CcSEcCtD
Alosetron—Hyperhidrosis—Etoposide—brain cancer	0.000178	0.00329	CcSEcCtD
Alosetron—Hypersensitivity—Carmustine—brain cancer	0.000175	0.00325	CcSEcCtD
Alosetron—Nausea—Hydroxyurea—brain cancer	0.000175	0.00324	CcSEcCtD
Alosetron—Asthenia—Carmustine—brain cancer	0.000171	0.00316	CcSEcCtD
Alosetron—Hypersensitivity—Temozolomide—brain cancer	0.000169	0.00314	CcSEcCtD
Alosetron—Asthenia—Temozolomide—brain cancer	0.000165	0.00305	CcSEcCtD
Alosetron—Fatigue—Etoposide—brain cancer	0.000159	0.00294	CcSEcCtD
Alosetron—Pain—Etoposide—brain cancer	0.000157	0.00291	CcSEcCtD
Alosetron—Constipation—Etoposide—brain cancer	0.000157	0.00291	CcSEcCtD
Alosetron—Feeling abnormal—Etoposide—brain cancer	0.000152	0.00281	CcSEcCtD
Alosetron—Vomiting—Carmustine—brain cancer	0.000151	0.0028	CcSEcCtD
Alosetron—Rash—Carmustine—brain cancer	0.00015	0.00278	CcSEcCtD
Alosetron—Dermatitis—Carmustine—brain cancer	0.00015	0.00277	CcSEcCtD
Alosetron—Headache—Carmustine—brain cancer	0.000149	0.00276	CcSEcCtD
Alosetron—Vomiting—Temozolomide—brain cancer	0.000146	0.00271	CcSEcCtD
Alosetron—Urticaria—Etoposide—brain cancer	0.000146	0.00271	CcSEcCtD
Alosetron—Rash—Temozolomide—brain cancer	0.000145	0.00268	CcSEcCtD
Alosetron—Dermatitis—Temozolomide—brain cancer	0.000145	0.00268	CcSEcCtD
Alosetron—Headache—Temozolomide—brain cancer	0.000144	0.00267	CcSEcCtD
Alosetron—Nausea—Carmustine—brain cancer	0.000141	0.00262	CcSEcCtD
Alosetron—Nausea—Temozolomide—brain cancer	0.000137	0.00253	CcSEcCtD
Alosetron—Hypersensitivity—Etoposide—brain cancer	0.000136	0.00251	CcSEcCtD
Alosetron—Asthenia—Etoposide—brain cancer	0.000132	0.00244	CcSEcCtD
Alosetron—Vomiting—Etoposide—brain cancer	0.000117	0.00217	CcSEcCtD
Alosetron—Rash—Etoposide—brain cancer	0.000116	0.00215	CcSEcCtD
Alosetron—Dermatitis—Etoposide—brain cancer	0.000116	0.00215	CcSEcCtD
Alosetron—Headache—Etoposide—brain cancer	0.000115	0.00213	CcSEcCtD
Alosetron—Nausea—Etoposide—brain cancer	0.000109	0.00202	CcSEcCtD
